Learn more about Peter Attia’s digital program
#129 – Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
“Atherogenic lipoproteins are really the issue behind clinical atherosclerotic vascular disease. … The data has just become so overwhelming.” —Tom Dayspring
Narrative glossary: lipids
A companion post for the podcast episodes with Thomas Dayspring, M.D., FACP, FNLA (October 15-19, 2018).
When does heart disease begin (and what this tells us about prevention)?
Before I get into this post I want to lay a few things out.
The straight dope on cholesterol – Part IX
In this post we’ll address the following concept: What should you eat to have the greatest chance of delaying the arrival of cardiovascular disease?
The straight dope on cholesterol – Part VIII
In this post we’ll double-click on a paper covering cholesterol and heart disease risk factors.
The straight dope on cholesterol – Part VII
In this post we’ll address the following concept: Does “HDL” matter after all?
The straight dope on cholesterol – Part VI
In this post we’ll address the following concept: Why is it necessary to measure LDL-P, instead of just LDL-C?
The straight dope on cholesterol – Part V
In this post we’ll address the following concept: Does the size of an LDL particle matter?
The straight dope on cholesterol – Part IV
In this post we’ll address the following concept: How does cholesterol actually cause problems?
The straight dope on cholesterol – Part III
In this post we’ll address the following concept: How do we measure cholesterol?